Glucotrack (GCTK) Total Non-Current Liabilities (2012 - 2025)
Glucotrack (GCTK) posted Total Non-Current Liabilities of $5.0 million for Q4 2025, down 9.52% on a QoQ basis from $5.5 million in Q3 2025, and up 231.5% year-over-year from $1.5 million in Q4 2024.
Glucotrack (GCTK) Total Non-Current Liabilities (2012 - 2025) Analysis & Trends
Glucotrack's Total Non-Current Liabilities history runs 14 years deep, the most recent figure standing at $5.0 million for Q4 2025.
- Quarterly Total Non-Current Liabilities rose 231.5% year-over-year to $5.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.0 million (up 231.5% YoY) and the FY2025 annual result came in at $5.0 million, up 231.5% from the prior year.
- Total Non-Current Liabilities was $5.0 million for Q4 2025 at Glucotrack, down from $5.5 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $5.5 million in Q3 2025 and bottomed at $184000.0 in Q3 2023.
- A 5-year average of $1.6 million and a median of $235000.0 in 2021 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2021 — Total Non-Current Liabilities plunged 42.54% — and 2024, when it jumped 2514.67%.
- Glucotrack's Total Non-Current Liabilities stood at $227000.0 in 2021, then retreated by 14.1% to $195000.0 in 2022, then surged by 675.38% to $1.5 million in 2023, then slipped by 0.07% to $1.5 million in 2024, then soared by 231.5% to $5.0 million in 2025.
- Business Quant data shows GCTK's Total Non-Current Liabilities at $5.0 million in Q4 2025, $5.5 million in Q3 2025, and $3.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 6.48 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 48.37 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 17.13 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 941.16 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 996.30 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 4.24 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 8.65 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 2.06 Bn |
| 10 | Glucotrack | 33.48 | -7.38 Mn | - | 5.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.01 Mn |
| Sep 30, 2025 | 5.54 Mn |
| Jun 30, 2025 | 3.33 Mn |
| Mar 31, 2025 | 2.18 Mn |
| Dec 31, 2024 | 1.51 Mn |
| Sep 30, 2024 | 4.81 Mn |
| Jun 30, 2024 | 3.71 Mn |
| Mar 31, 2024 | 1.54 Mn |
| Dec 31, 2023 | 1.51 Mn |
| Sep 30, 2023 | 184,000.00 |
| Jun 30, 2023 | 189,000.00 |
| Mar 31, 2023 | 193,000.00 |
| Dec 31, 2022 | 195,000.00 |
| Sep 30, 2022 | 191,000.00 |
| Jun 30, 2022 | 192,000.00 |
| Mar 31, 2022 | 212,000.00 |
| Dec 31, 2021 | 227,000.00 |
| Sep 30, 2021 | 234,000.00 |
| Jun 30, 2021 | 236,000.00 |
| Mar 31, 2021 | 231,000.00 |